Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> SANOFI Latest News

SEP 17, 2014 - Yahoo! News

A Must Read - Share

Sanofi unveils heart disease partnership with MyoKardia

PARIS (Reuters) - French drugmaker Sanofi announced on Wednesday a partnership with U.S.-based MyoKardia to develop therapies for patients with genetic heart diseases. The collaboration includes up to $200 million in equity investments, milestone payments, and research and development services through 2018, Sanofi said in a statement. MyoKardia was founded in 2012 and is funded by healthcare investor Third Rock ...

Tags: Sanofi unveils heart disease partnership with MyoKardia,  Sanofi Latest News

SEP 15, 2014 - Yahoo! News

A Must Read - Share

CORRECTION: Educational apps help kids take control of their health

Sanofi Diabetes, a division of Sanofi-Aventis, has launched an app in the UK oriented towards kids with type 1 diabetes and their friends, parents and caregivers called Mission T1D. The setting is a virtual school in which players earn their knowledge when they win enough points to unlock short, easy-to-remember tips about living with type 1 diabetes and in some ...

Tags: CORRECTION: Educational apps help kids take control of their health,  Sanofi Latest News

SEP 13, 2014 - Yahoo! News

A Must Read - Share

Sanofi aims to grow Genzyme unit with new drugs and acquisitions

In the 10th paragraph, the quote should be attributed to Bill Sibold, not Mike Panzara) Sanofi rare disease unit Genzyme hopes to become a leader in the multiple sclerosis (MS) field with the help of new products developed in-house but also through acquisitions, senior Genzyme executives told Reuters. The Cambridge, Massachusetts company is confident in the commercial success of its ...

Tags: Sanofi aims to grow Genzyme unit with new drugs and acquisitions,  Sanofi Latest News

SEP 11, 2014 - Yahoo! News

A Must Read - Share

Sanofi says MS drug Lemtrada shows sustained effect on disease

Sanofi rare disease unit Genzyme said its Lemtrada multiple sclerosis (MS) drug showed continued efficacy for four years in more than two thirds of patients and that no new safety risks had been identified in its latest studies. Approximately 70 percent of patients who received Lemtrada in two courses of treatment over two years did not need to receive further ...

Tags: Sanofi says MS drug Lemtrada shows sustained effect on disease,  Sanofi Latest News

SEP 10, 2014 - Yahoo! News

A Must Read - Share

Lilly, Boehringer copy of Sanofi's insulin gets EU approval

(Reuters) - Eli Lilly and Co and Boehringer Ingelheim said on Wednesday that the European Commission approved their copycat version of Sanofi SA's blockbuster insulin, Lantus. The treatment, to be manufactured by Lilly, comprises a type of basal insulin, intended to provide long-lasting blood sugar control between meals and at night. The therapy received a positive recommendation from the European ...

Tags: Lilly, Boehringer copy of Sanofi's insulin gets EU approval,  Sanofi Latest News